Literature DB >> 17416758

Dietary flavonoids and the risk of colorectal cancer.

Evropi Theodoratou1, Janet Kyle, Roseanne Cetnarskyj, Susan M Farrington, Albert Tenesa, Rebecca Barnetson, Mary Porteous, Malcolm Dunlop, Harry Campbell.   

Abstract

In vitro and in vivo laboratory data point to chemoprotective effects of flavonoids on colorectal cancer. However, there has been limited epidemiologic research on the dietary intake of flavonoids and risk of colorectal cancer. Recent expansions of dietary databases to include flavonoid data now make such studies feasible. Association between the six main classes of flavonoids and the risk of colorectal cancer was examined using data from a national prospective case-control study in Scotland, including 1,456 incident cases and 1,456 population-based controls matched on age, sex, and residence area. Dietary, including flavonoid data, were obtained from a validated, self-administered food frequency questionnaire. Risk of colorectal cancer was estimated using conditional logistic regression models in the whole sample and stratified by sex, smoking status, and cancer site and adjusted for established and putative risk factors. After energy adjustment, reductions in colorectal cancer risk associated with the highest quartiles of intake (versus the lowest quartile) were 27% for flavonols [odds ratio (OR), 0.73; P(trend) = 0.012], 32% for quercetin (OR, 0.68; P(trend) = 0.001), 32% for catechin (OR, 0.68; P(trend) < 0.0005); 26% for epicatechin (OR, 0.74; P(trend) = 0.019), and 22% for procyanidins (OR, 0.78; P(trend) = 0.031). The significant dose-dependent reductions in colorectal cancer risk that were associated with increased consumption of flavonols, quercetin, catechin, and epicatechin remained robust after controlling for overall fruit and vegetable consumption or for other flavonoid intake. The risk reductions were greater among nonsmokers, but no interaction beyond a multiplicative effect was present. Sex-specific or cancer-type differences were not observed. No risk reductions were associated with intake of flavones (P(trend) = 0.64), flavonones (P(trend) = 0.22), and phytoestrogens (P(trend) = 0.26). This was the first of several a priori hypotheses to be tested in this large study and showed strong and linear inverse associations of flavonoids with colorectal cancer risk.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17416758     DOI: 10.1158/1055-9965.EPI-06-0785

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  59 in total

1.  Phenolic metabolites and substantial microbiome changes in pig feces by ingesting grape seed proanthocyanidins.

Authors:  Ying Yng Choy; Paola Quifer-Rada; Dirk M Holstege; Steven A Frese; Christopher C Calvert; David A Mills; Rosa M Lamuela-Raventos; Andrew L Waterhouse
Journal:  Food Funct       Date:  2014-09       Impact factor: 5.396

2.  Ten common genetic variants associated with colorectal cancer risk are not associated with survival after diagnosis.

Authors:  Albert Tenesa; Evropi Theodoratou; Farhat V N Din; Susan M Farrington; Roseanne Cetnarskyj; Rebecca A Barnetson; Mary E Porteous; Harry Campbell; Malcolm G Dunlop
Journal:  Clin Cancer Res       Date:  2010-07-13       Impact factor: 12.531

3.  Myricetin induces pancreatic cancer cell death via the induction of apoptosis and inhibition of the phosphatidylinositol 3-kinase (PI3K) signaling pathway.

Authors:  P A Phillips; V Sangwan; D Borja-Cacho; V Dudeja; S M Vickers; A K Saluja
Journal:  Cancer Lett       Date:  2011-06-14       Impact factor: 8.679

4.  Dietary lignan and proanthocyanidin consumption and colorectal adenoma recurrence in the Polyp Prevention Trial.

Authors:  Gerd Bobe; Gwen Murphy; Paul S Albert; Leah B Sansbury; Elaine Lanza; Arthur Schatzkin; Amanda J Cross
Journal:  Int J Cancer       Date:  2011-08-01       Impact factor: 7.396

5.  Dietary flavonoid intake and colorectal cancer risk in the European prospective investigation into cancer and nutrition (EPIC) cohort.

Authors:  Raul Zamora-Ros; Dinesh K Barupal; Joseph A Rothwell; Mazda Jenab; Veronika Fedirko; Isabelle Romieu; Krasimira Aleksandrova; Kim Overvad; Cecilie Kyrø; Anne Tjønneland; Aurélie Affret; Mathilde His; Marie-Christine Boutron-Ruault; Verena Katzke; Tilman Kühn; Heiner Boeing; Antonia Trichopoulou; Androniki Naska; Maria Kritikou; Calogero Saieva; Claudia Agnoli; Maria Santucci de Magistris; Rosario Tumino; Francesca Fasanelli; Elisabete Weiderpass; Guri Skeie; Susana Merino; Paula Jakszyn; Maria-José Sánchez; Miren Dorronsoro; Carmen Navarro; Eva Ardanaz; Emily Sonestedt; Ulrika Ericson; Lena Maria Nilsson; Stina Bodén; H B As Bueno-de-Mesquita; Petra H Peeters; Aurora Perez-Cornago; Nicholas J Wareham; Kay-Thee Khaw; Heinz Freisling; Amanda J Cross; Elio Riboli; Augustin Scalbert
Journal:  Int J Cancer       Date:  2017-01-19       Impact factor: 7.396

6.  Estrogens, phytoestrogens and colorectal neoproliferative lesions.

Authors:  Michele Barone; Sabina Tanzi; Katia Lofano; Maria Principia Scavo; Raffaella Guido; Lucia Demarinis; Maria Beatrice Principi; Antongiulio Bucci; Alfredo Di Leo
Journal:  Genes Nutr       Date:  2008-04       Impact factor: 5.523

7.  Kaempferol inhibits angiogenesis and VEGF expression through both HIF dependent and independent pathways in human ovarian cancer cells.

Authors:  Haitao Luo; Gary O Rankin; Lingzhi Liu; Matthew K Daddysman; Bing-Hua Jiang; Yi Charlie Chen
Journal:  Nutr Cancer       Date:  2009       Impact factor: 2.900

8.  Kaempferol enhances cisplatin's effect on ovarian cancer cells through promoting apoptosis caused by down regulation of cMyc.

Authors:  Haitao Luo; Matthew K Daddysman; Gary O Rankin; Bing-Hua Jiang; Yi C Chen
Journal:  Cancer Cell Int       Date:  2010-05-11       Impact factor: 5.722

9.  Serum cytokine concentrations, flavonol intake and colorectal adenoma recurrence in the Polyp Prevention Trial.

Authors:  G Bobe; G Murphy; P S Albert; L B Sansbury; E Lanza; A Schatzkin; N H Colburn; A J Cross
Journal:  Br J Cancer       Date:  2010-10-05       Impact factor: 7.640

10.  Phytoestrogen consumption and endometrial cancer risk: a population-based case-control study in New Jersey.

Authors:  Elisa V Bandera; Melony G Williams; Camelia Sima; Sharon Bayuga; Katherine Pulick; Homer Wilcox; Robert Soslow; Ann G Zauber; Sara H Olson
Journal:  Cancer Causes Control       Date:  2009-04-08       Impact factor: 2.506

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.